These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9330647)

  • 1. [Anxiety and depression. Highlights from the 149th Session of the American Psychiatric Association, New York 4-9 May 1996].
    Fortschr Neurol Psychiatr; 1997 Apr; 65(4 Suppl Angst Und):1-4. PubMed ID: 9330647
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized anxiety disorder in family practice patients.
    Magill MK; Gunning K
    Am Fam Physician; 2000 Oct; 62(7):1497, 1501-2, 1504. PubMed ID: 11037071
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of buspirone in clinical practice].
    Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(4):83-87. PubMed ID: 26288293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of buspirone for treatment of cerebellar ataxia. An open-label study.
    Lou JS; Goldfarb L; McShane L; Gatev P; Hallett M
    Arch Neurol; 1995 Oct; 52(10):982-8. PubMed ID: 7575226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation with buspirone: a review.
    Harvey KV; Balon R
    Ann Clin Psychiatry; 1995 Sep; 7(3):143-7. PubMed ID: 8646275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Azaspirodecanodiones in clinical psychiatry].
    Conde López V; Martínez Roig M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(4):155-67. PubMed ID: 1356293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 8. Buspirone for anxiety and agitation in dementia.
    Cooper JP
    J Psychiatry Neurosci; 2003 Nov; 28(6):469. PubMed ID: 14631458
    [No Abstract]   [Full Text] [Related]  

  • 9. The use and development of anxiolytics in Japan.
    Yamawaki S
    Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S413-9. PubMed ID: 10622688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of buspirone in primary care.
    Khouzam HR; Emes R
    J Psychosoc Nurs Ment Health Serv; 2002 Jul; 40(7):34-41. PubMed ID: 12136514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine indole alkaloids: potential new drug leads for the control of depression and anxiety.
    Kochanowska-Karamyan AJ; Hamann MT
    Chem Rev; 2010 Aug; 110(8):4489-97. PubMed ID: 20380420
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin partial agonists in the treatment of anxiety and depression. Proceedings from the VIII World Congress of Psychiatry. Athens, Greece, October 12-19, 1989.
    J Clin Psychiatry; 1990 Sep; 51 Suppl():30-66. PubMed ID: 1976624
    [No Abstract]   [Full Text] [Related]  

  • 13. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone for stereotypic movements in elderly with cognitive impairment.
    Helvink B; Holroyd S
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):242-4. PubMed ID: 16720804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression.
    Pfeffer CR; Jiang H; Domeshek LJ
    J Child Adolesc Psychopharmacol; 1997; 7(3):145-55. PubMed ID: 9466232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correspondence (reply): In reply.
    Bandelow B; Boerner RJ; Kasper S; Linden M; Wittchen HU; Möller HJ
    Dtsch Arztebl Int; 2013 Sep; 110(37):610-1. PubMed ID: 24078852
    [No Abstract]   [Full Text] [Related]  

  • 17. Bristol-Myers Squibb pushes BuSpar compliance.
    Telemed Virtual Real; 1998 Dec; 3(12):144. PubMed ID: 10345193
    [No Abstract]   [Full Text] [Related]  

  • 18. Correspondence (letter to the editor): Professional and ethical criticism.
    Müller W
    Dtsch Arztebl Int; 2013 Sep; 110(37):610. PubMed ID: 24078851
    [No Abstract]   [Full Text] [Related]  

  • 19. Correspondence (letter to the editor): Regular muscle activity.
    Hofmeister M
    Dtsch Arztebl Int; 2013 Sep; 110(37):610. PubMed ID: 24078850
    [No Abstract]   [Full Text] [Related]  

  • 20. Correspondence (letter to the editor): One-sided publication.
    Egidi G
    Dtsch Arztebl Int; 2013 Sep; 110(37):609. PubMed ID: 24078849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.